文献速递妇科产科

北欧年轻女性妇科癌症发病与生存趋势(1980-2023)

Incidence, prevalence, mortality and survival trends in women with endometrial-, ovarian- and cervical cancer in the Nordic countries (1980-2023) with focus on younger women (0-49 years old).
PubMed 文献 · Gynecol Oncol · 2026-08-19

基于NORDCAN登记数据,分析北欧0-49岁女性1980-2023年子宫内膜癌、卵巢癌和宫颈癌的发病、患病、死亡及五年相对生存趋势。子宫内膜癌发病率上升36%,卵巢癌和宫颈癌发病率分别下降50%和15%;卵巢癌和宫颈癌死亡率分别下降75%和67%,子宫内膜癌死亡率稳定在≤0.2/10万;三种癌症五年相对生存率均较高或改善。

要点

  • 子宫内膜癌发病率在年轻女性中上升36%,需关注肥胖等预防策略。
  • 卵巢癌和宫颈癌发病率下降,死亡率大幅下降,生存率改善。
  • 宫颈癌五年相对生存率从77-83%升至89-93%,卵巢癌从48-64%升至68-81%。

核心结论

  • 北欧年轻女性妇科癌症趋势各异:子宫内膜癌发病率上升,卵巢癌和宫颈癌发病率下降且死亡率降低,生存率改善。

研究设计与样本

  • 基于NORDCAN人群登记数据,纳入1980-2023年北欧0-49岁确诊子宫内膜癌、卵巢癌或宫颈癌的女性,年龄标准化计算发病率、患病率、死亡率和五年相对生存率(Pohar-Perme法)。

主要发现

  • 子宫内膜癌发病率从1998-2000年的1.4例/10万人年升至2021-2023年的1.9例/10万人年(增加36%)。
  • 卵巢癌发病率从4.2降至2.1例/10万人年(下降50%),宫颈癌从6.5降至5.5例/10万人年(下降15%)。
  • 卵巢癌死亡率从1.9降至0.6例/10万人年(下降75%),宫颈癌从1.5降至0.5例/10万人年(下降67%),子宫内膜癌死亡率稳定在≤0.2例/10万人年。
  • 子宫内膜癌五年相对生存率维持在90-95%;宫颈癌从1979-1983年的77-83%升至2019-2023年的89-93%;卵巢癌从48-64%升至68-81%。

临床怎么用

  • 针对年轻女性应强调年龄特异性预防策略,包括肥胖预防、监测避孕趋势以及继续实施HPV筛查和疫苗接种。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Endometrial, ovarian, and cervical cancers predominantly affect middle-aged and older women, but temporal trends may differ in younger women due to distinct risk factors and clinical characteristics. We therefore assessed temporal trends in incidence, prevalence, mortality, and survival across these cancers in younger women. METHODS: Using population-based NORDCAN registry data, we identified women aged 0-49 years diagnosed with endometrial, ovarian, or cervical cancer in the Nordic countries between 1980 and 2023. Incidence, prevalence, mortality, and five-year relative survival (RS) were age-standardized, with the latter estimated using the Pohar-Perme method. RESULTS: Endometrial cancer incidence rates increased from 1.4 to 1.9 cases per 100,000 person-years (PY) between 1998 and 2000 and 2021-2023 (36% increase). Over the full study period, incidence rates declined for both ovarian cancer (4.2 to 2.1 cases per 100,000 PY; 50% decrease) and cervical cancer (6.5 to 5.5 cases per 100,000 PY; 15% decrease). Mortality rates decreased for women with ovarian cancer (1.9 to 0.6 per 100,000 PY; 75% decrease) and cervical cancer (1.5 to 0.5 per 100 00 PY; 67% decrease), while remaining steady at ≤ 0.2 per 100,000 PY for endometrial cancer. RS estimates remained high for endometrial cancer (90-95%). Cervical cancer five-year RS improved from 77-83% in 1979-1983 to 89-93% in 2019-2023, while ovarian cancer increased from 48-64% to 68-81%. CONCLUSIONS: Gynecological cancers show distinct temporal trends among young women in the Nordic countries. These findings underscore the importance of age-specific prevention strategies, including obesity prevention, monitoring contraceptive trends, and continued implementation of HPV-based screening and vaccination.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Riese C, Chen EY, Nilsson H, et al. Incidence, prevalence, mortality and survival trends in women with endometrial-, ovarian- and cervical cancer in the Nordic countries (1980-2023) with focus on younger women (0-49 years old). Gynecol Oncol. 2026. PMID: 42617581. doi:10.1016/j.ygyno.2026.08.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。